Spyre Therapeutics, Inc.
NASDAQ:SYREBiotechnology
Healthcare
$97.63 +1.38%
+$1.21 today
- Market cap
- $9.27B
- Beta
- 3.06
- P/E (TTM)
- -171.1
- EPS (TTM)
- -$0.52
52W Low $14.00High $91.04
Volume 0.63M
Average 1.17M
Price history
Spyre Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+315.98%
Period high
$109.00
Period low
$23.47
Latest
$97.63
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 3, 2026 | Nov 3, 2026 | |
| 10-Q | Nov 3, 2026 | Nov 3, 2026 | |
| SC 13D/A | Oct 9, 2026 | Oct 9, 2026 | |
| 8-K | Oct 7, 2026 | Oct 7, 2026 | |
| 424B5 | Oct 6, 2026 | Oct 6, 2026 | |
| 424B5 | Oct 5, 2026 | Oct 5, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| SC 13G | Oct 1, 2026 | Oct 1, 2026 | |
| 8-K | Sep 8, 2026 | Sep 8, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 144 | Sep 1, 2026 | Sep 1, 2026 |
Competitors
Who does Spyre Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about SYRE's filings, answered from its disclosures.
What is the latest SYRE filing?
The latest filing shown is 10-Q dated Nov 3, 2026.
How many recent filings does SYRE have?
Intrinsic Alpha currently shows 20 recent filings for SYRE.
Continue the stock analysis
Jump to another research area for this company.